<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li X</submitter><funding>National Natural Science Foundation of China</funding><pagination>1500-1512</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9345959</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(8)</volume><pubmed_abstract>Caspase-8 is an initiator of death receptor-induced apoptosis and an inhibitor of RIPK3-MLKL-dependent necroptosis. In addition, caspase-8 has been implicated in diseases such as lymphoproliferation, immunodeficiency, and autoimmunity in humans. Although auto-cleavage is indispensable for caspase-8 activation, its physiological functions remain poorly understood. Here, we generated a caspase-8 mutant lacking E385 in auto-cleavage site knock-in mouse (Casp8&lt;sup>ΔE385/ΔE385&lt;/sup>). Casp8&lt;sup>ΔE385/ΔE385&lt;/sup> cells were expectedly resistant to Fas-induced apoptosis, however, Casp8&lt;sup>ΔE385/ΔE385&lt;/sup> cells could switch TNF-α-induced apoptosis to necroptosis by attenuating RIPK1 cleavage. More importantly, CASP8(ΔE385) sensitized cells to RIPK3-MLKL-dependent necroptosis through promoting c</pubmed_abstract><journal>Cell death and differentiation</journal><pubmed_title>Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3/MLKL to prevent lymphopenia.</pubmed_title><pmcid>PMC9345959</pmcid><funding_grant_id>31771537</funding_grant_id><funding_grant_id>82001684</funding_grant_id><funding_grant_id>31970688</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Deng J</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Xing M</pubmed_authors><pubmed_authors>Zhao Q</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Ou Y</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3/MLKL to prevent lymphopenia.</name><description>Caspase-8 is an initiator of death receptor-induced apoptosis and an inhibitor of RIPK3-MLKL-dependent necroptosis. In addition, caspase-8 has been implicated in diseases such as lymphoproliferation, immunodeficiency, and autoimmunity in humans. Although auto-cleavage is indispensable for caspase-8 activation, its physiological functions remain poorly understood. Here, we generated a caspase-8 mutant lacking E385 in auto-cleavage site knock-in mouse (Casp8&lt;sup>ΔE385/ΔE385&lt;/sup>). Casp8&lt;sup>ΔE385/ΔE385&lt;/sup> cells were expectedly resistant to Fas-induced apoptosis, however, Casp8&lt;sup>ΔE385/ΔE385&lt;/sup> cells could switch TNF-α-induced apoptosis to necroptosis by attenuating RIPK1 cleavage. More importantly, CASP8(ΔE385) sensitized cells to RIPK3-MLKL-dependent necroptosis through promoting c</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-26T11:57:09.635Z</modification><creation>2025-02-19T05:06:14.828Z</creation></dates><accession>S-EPMC9345959</accession><cross_references><pubmed>35064213</pubmed><doi>10.1038/s41418-022-00938-9</doi></cross_references></HashMap>